Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.

[1]  B. Payne,et al.  Determinants of response to repeat hepatitis B vaccination in HIV-infected prior non-responders. , 2014, The Journal of infection.

[2]  R. Chaiwarith,et al.  Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled Trial , 2013, PloS one.

[3]  C. Leen,et al.  British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013 , 2013, HIV medicine.

[4]  J. Ni,et al.  Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis? , 2013, International journal of STD & AIDS.

[5]  L. Camacho,et al.  Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults. , 2012, Vaccine.

[6]  F. Carrat,et al.  Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. , 2011, JAMA.

[7]  B. Kapogiannis,et al.  Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens , 2011, Journal of acquired immune deficiency syndromes.

[8]  P. Malani,et al.  Factors Associated With Seroconversion After Standard Dose Hepatitis B Vaccination and High-Dose Revaccination Among HIV-Infected Patients , 2010 .

[9]  L. Camacho,et al.  High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects. , 2010, Vaccine.

[10]  John T Brooks,et al.  Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  C. Mengoli,et al.  Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. , 2009, Vaccine.

[12]  D. Neau,et al.  Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  R. D. de Man,et al.  A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. , 2008, The Journal of infectious diseases.

[14]  M. Alter,et al.  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States , 2006, Pediatrics.

[15]  Giorgio Palù,et al.  Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. , 2005, Journal of hepatology.

[16]  A. Barone,et al.  Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. , 2005, Vaccine.

[17]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[18]  R. Jacobson,et al.  Prevention of Hepatitis B with the Hepatitis B Vaccine , 2004 .

[19]  A. McNaghten,et al.  Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. , 2003, The Journal of infectious diseases.

[20]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[21]  J. Lang,et al.  Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. , 2000, Vaccine.

[22]  S. Lemon,et al.  Vaccines to prevent viral hepatitis. , 1997, The New England journal of medicine.

[23]  Tayal Sc,et al.  Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. , 1994 .

[24]  I. Keet,et al.  Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. , 1992, AIDS.

[25]  M. Bruguera,et al.  Impaired Response to Recombinant Hepatitis B Vaccine in HIV‐Infected Persons , 1992, Journal of clinical gastroenterology.

[26]  B. McMahon,et al.  Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. , 1991, Archives of internal medicine.

[27]  S. Hadler,et al.  Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. , 1986, The New England journal of medicine.